1. Bell, C.; Frost, P.; Kerbel, R. S. Cytogenetic heterogenity of genetically marked and metastatically competent “Dominant” tumor cell clones. Cancer Genet. Cytogenet. 54:153–161; 1991.
2. Brison, O. Gene amplification and tumor progression. Biochim. Biophys. Acta 1155:25–41; 1993.
3. Calabresi, P.; Dexter, D. L. Clinical applications of cancer cell heterogeneity. In: Owens, A. H.; Coffey, D. S.; Baylin, S. B., eds. Tumor cell heterogeneity: origins and implications. New York: Academic Press; 1982:181–201.
4. Chakrabarti, S.; Granzow, C. Frequent involvement of Ig heavy chain carrier chromosome 12 in translocations in an Ehrlich-derived mouse tumor line. Neoplasma 39:237–239; 1992.
5. Cheng, K. C.; Loeb, L. A. Genomic instability and tumor progression: mechanistic considerations. Adv. Cancer Res. 60:121–156; 1993.